Rufinamide
DrugBank ID: DB06201
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 2 |
| DL Only | 48 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| Lennox-Gastaut syndrome | 0.9959 | KG+DL |
| febrile infection-related epilepsy syndrome | 0.9957 | DL |
| perioral myoclonia with absences | 0.9951 | DL |
| atypical childhood epilepsy with centrotemporal spikes | 0.9944 | DL |
| cryptogenic late-onset epileptic spasms | 0.9944 | DL |
| photosensitive occipital lobe epilepsy | 0.9944 | DL |
| cutis verticis gyrata | 0.9866 | KG+DL |
| trigeminal nerve neoplasm | 0.9791 | DL |
| benign occipital epilepsy | 0.9775 | DL |
| childhood onset epileptic encephalopathy | 0.9771 | DL |
| early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation | 0.9637 | DL |
| renal-hepatic-pancreatic dysplasia | 0.9626 | DL |
| polycystic kidney disease 3 with or without polycystic liver disease | 0.9553 | DL |
| Joubert syndrome with renal defect | 0.9537 | DL |
| karyomegalic interstitial nephritis | 0.9522 | DL |
| thoracic malformation | 0.9515 | DL |
| adult familial nephronophthisis-spastic quadriparesia syndrome | 0.9498 | DL |
| early onset absence epilepsy | 0.9489 | DL |
| acute encephalopathy with biphasic seizures and late reduced diffusion | 0.9486 | DL |
| trigeminal neuralgia | 0.9346 | DL |
| familial hemiplegic migraine | 0.9328 | DL |
| polycystic kidney disease | 0.9056 | DL |
| polymicrogyria with optic nerve hypoplasia | 0.9000 | DL |
| rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome | 0.8943 | DL |
| intellectual disability-hypotonia-spasticity-sleep disorder syndrome | 0.8844 | DL |
| PSAT deficiency | 0.8792 | DL |
| nodular neuronal heterotopia | 0.8790 | DL |
| polyhydramnios, megalencephaly, and symptomatic epilepsy | 0.8758 | DL |
| reading seizures | 0.8673 | DL |
| central nervous system calcification-deafness-tubular acidosis-anemia syndrome | 0.8663 | DL |
| glutamate pyruvate transaminase 2 deficiency | 0.8638 | DL |
| microlissencephaly-micromelia syndrome | 0.8596 | DL |
| congenital insensitivity to pain with severe intellectual disability | 0.8587 | DL |
| developmental and speech delay due to SOX5 deficiency | 0.8586 | DL |
| audiogenic seizures | 0.8582 | DL |
| eating seizures | 0.8582 | DL |
| micturation-induced seizures | 0.8582 | DL |
| orgasm-induced seizures | 0.8582 | DL |
| startle epilepsy | 0.8582 | DL |
| thinking seizures | 0.8582 | DL |
| recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome | 0.8580 | DL |
| polymicrogyria | 0.8579 | DL |
| global developmental delay-osteopenia-ectodermal defect syndrome | 0.8574 | DL |
| Al Kaissi syndrome | 0.8572 | DL |
| hypotrichosis-intellectual disability, Lopes type | 0.8569 | DL |
| developmental delay and seizures with or without movement abnormalities | 0.8567 | DL |
| idiopathic hemiconvulsion-hemiplegia syndrome | 0.8564 | DL |
| PSPH deficiency | 0.8551 | DL |
| Gomez-Lopez-Hernandez syndrome | 0.8543 | DL |
| serine biosynthesis pathway deficiency, infantile/juvenile form | 0.8541 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.